In our annual report, discover a retrospective of the year 2023: highlights, achievements and key figures. Explore our landmark projects and their tangible impact.
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.